David Joseph


  • The University of Western Australia (M509), 35 Stirling Highway,

    6009 Perth


  • 3011 Citations
  • 27 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where David Joseph is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles
Radiotherapy Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Androgens Medicine & Life Sciences
Prostate Medicine & Life Sciences
Exercise Medicine & Life Sciences
zoledronic acid Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Brachytherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

Evaluation of a mobile C‐arm cone‐beam CT in interstitial high‐dose‐rate prostate brachytherapy treatment planning

Djukelic, M., Waterhouse, D., Toh, R., Tan, H. T., Rowshan Farzad, P., Joseph, D. & Ebert, M., 1 Jun 2019, In : Journal of Medical Radiation Sciences. 66, 2, p. 112-121 10 p.

Research output: Contribution to journalArticle

Open Access
Fiducial Markers

Exercise mode specificity for preserving spine and hip bone mineral density in prostate cancer patients

Newton, R. U., Galvão, D. A., Spry, N., Joseph, D., Chambers, S. K., Gardiner, R. A., Wall, B. A., Bolam, K. A. & Taaffe, D. R., 1 Apr 2019, In : Medicine and Science in Sports and Exercise. 51, 4, p. 607-614 8 p.

Research output: Contribution to journalArticle

Pelvic Bones
Bone Density
Prostatic Neoplasms
1 Citation (Scopus)

Immediate versus delayed exercise in men initiating androgen deprivation: effects on bone density and soft tissue composition

Taaffe, D. R., Galvao, D. A., Spry, N., Joseph, D., Chambers, S. K., Gardiner, R. A., Hayne, D., Cormie, P., Shum, D. H. K. & Newton, R. U., Feb 2019, In : BJU International. 123, 2, p. 261-269 9 p.

Research output: Contribution to journalArticle

Open Access
Open Access
5 Citations (Scopus)

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial

Denham, J. W., Joseph, D., Lamb, D. S., Spry, N. A., Duchesne, G., Matthews, J., Atkinson, C., Tai, K. H., Christie, D., Kenny, L., Turner, S., Gogna, N. K., Diamond, T., Delahunt, B., Oldmeadow, C., Attia, J. & Steigler, A., 1 Feb 2019, In : The Lancet Oncology. 20, 2, p. 267-281 15 p.

Research output: Contribution to journalArticle

zoledronic acid
Prostatic Neoplasms
New Zealand

Projects 2006 2015